These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11062202)

  • 1. In vitro susceptibility of Helicobacter pylori to, and in vivo suppression by, antimicrobials used in selective decontamination of the digestive tract.
    van der Voort PH; van der Hulst RW; Zandstra DF; van der Ende A; Geraedts AA; Tytgat GN
    J Antimicrob Chemother; 2000 Nov; 46(5):803-5. PubMed ID: 11062202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut decontamination of critically ill patients reduces Helicobacter pylori acquisition by intensive care nurses.
    van der Voort PH; van der Hulst RW; Zandstra DF; van der Ende A; Kesecioglu J; Geraedts AA; Tytgat GN
    J Hosp Infect; 2001 Jan; 47(1):41-5. PubMed ID: 11161897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Decontamination of the digestive tract during recovery from anesthesia].
    Brun-Buisson C
    Rev Prat; 1990 Nov; 40(25):2320-3. PubMed ID: 2175935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis.
    Daneman N; Sarwar S; Fowler RA; Cuthbertson BH;
    Lancet Infect Dis; 2013 Apr; 13(4):328-41. PubMed ID: 23352693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective decontamination of the digestive tract: a stratified, randomized, prospective study in a mixed intensive care unit.
    Blair P; Rowlands BJ; Lowry K; Webb H; Armstrong P; Smilie J
    Surgery; 1991 Aug; 110(2):303-9; discussion 309-10. PubMed ID: 1650036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of selective decontamination on antimicrobial resistance.
    Hammond JM; Potgieter PD
    Crit Care Med; 1995 Apr; 23(4):637-45. PubMed ID: 7712753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo combinations of cefotaxime and minocycline against Aeromonas hydrophila.
    Ko WC; Lee HC; Chuang YC; Ten SH; Su CY; Wu JJ
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1281-3. PubMed ID: 11257047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Selective decontamination of the digestive tract reduces mortality in intensive care patients].
    Rommes JH; Zandstra DF; van Saene HK
    Ned Tijdschr Geneeskd; 1999 Mar; 143(12):602-6. PubMed ID: 10321285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a role for selective decontamination of the digestive tract in primarily infected patients in the ICU?
    Hammond JM; Potgieter PD
    Anaesth Intensive Care; 1995 Apr; 23(2):168-74. PubMed ID: 7793587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of Helicobacter pylori to antibiotics in Chinese patients.
    Bai P; Zhou LY; Xiao XM; Luo Y; Ding Y
    J Dig Dis; 2015 Aug; 16(8):464-70. PubMed ID: 26147515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective intestinal decontamination in multiple trauma patients: prospective, controlled trial.
    Lingnau W; Berger J; Javorsky F; Lejeune P; Mutz N; Benzer H
    J Trauma; 1997 Apr; 42(4):687-94. PubMed ID: 9137259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of treatment of Helicobacter pylori on the normal gastrointestinal microflora.
    Adamsson I; Edlund C; Nord CE
    Clin Microbiol Infect; 2000 Apr; 6(4):175-7. PubMed ID: 11168104
    [No Abstract]   [Full Text] [Related]  

  • 13. The prevention of anastomotic leakage after total gastrectomy with local decontamination. A prospective, randomized, double-blind, placebo-controlled multicenter trial.
    Schardey HM; Joosten U; Finke U; Staubach KH; Schauer R; Heiss A; Kooistra A; Rau HG; Nibler R; Lüdeling S; Unertl K; Ruckdeschel G; Exner H; Schildberg FW
    Ann Surg; 1997 Feb; 225(2):172-80. PubMed ID: 9065294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the preliminary susceptibility testing for initial and after failed therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and esomeprazole.
    Marzio L; Coraggio D; Capodicasa S; Grossi L; Cappello G
    Helicobacter; 2006 Aug; 11(4):237-42. PubMed ID: 16882326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the immune status of mice during and following selective decontamination of the digestive tract.
    Speekenbrink AB; Alcock SR; Parrott DM
    Epidemiol Infect; 1989 Oct; 103(2):323-32. PubMed ID: 2806417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Culture-based selection therapy for patients who did not respond to previous treatment for Helicobacter pylori infection.
    Fiorini G; Vakil N; Zullo A; Saracino IM; Castelli V; Ricci C; Zaccaro C; Gatta L; Vaira D
    Clin Gastroenterol Hepatol; 2013 May; 11(5):507-10. PubMed ID: 23267869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of a post-antibiotic effect (PAE) of beta-lactams against Helicobacter pylori NCTC 11637.
    Hassan IJ; Stark RM; Greenman J; Millar MR
    J Antimicrob Chemother; 1998 Nov; 42(5):661-3. PubMed ID: 9848453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori antimicrobial resistance during a 5-year period (2013-2017) in northern Spain and its relationship with the eradication therapies.
    Cosme A; Torrente Iranzo S; Montes Ros M; Fernández-Reyes Silvestre M; Alonso Galán H; Lizasoain J; Bujanda L
    Helicobacter; 2019 Feb; 24(1):e12557. PubMed ID: 30460730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of real-time PCR-based detection of Helicobacter pylori infection and genotypic resistance-guided quadruple therapy as the first-line treatment for functional dyspepsia with Helicobacter pylori infection.
    Liu Q; Qi D; Kang J; Jin Y; Liu W; Gao W; Hou P; Lu J
    Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):221-5. PubMed ID: 25629566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple regimen of selective decontamination of the digestive tract, systemic cefotaxime, and microbiological surveillance for prevention of acquired infection in intensive care.
    Ledingham IM; Alcock SR; Eastaway AT; McDonald JC; McKay IC; Ramsay G
    Lancet; 1988 Apr; 1(8589):785-90. PubMed ID: 2895316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.